Last update May 1, 2016
Very Low Risk
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
アセクロフェナク is Aceclofenac in Japanese.Is written in other languages:
アセクロフェナク belongs to this group or family:
Main tradenames from several countries containing アセクロフェナク in its composition:
|Protein Binding||> 99||%|
|Tmax||1 - 3||hours|
Write us at firstname.lastname@example.org
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Antiinflammatory drug that is similar to diclofenac and used in the treatment of rheumatoid arthritis, ankylosing spondylitis and osteoartrirts.
At latest update no published data on excretion into breast milk were found.
Its high plasma protein-binding capacity makes the passage into milk be unlikely.
Diclofenac which is part of the same family of antiinflammatory drugs is excreted in non-significant amount into breast milk.